Skip to content

Clinical trials

Coronavirus Infections trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Country / region: South Korea Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20181
20191
20203
20212
20222
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Active, not recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
Ansun Biopharma, Inc.1
Asan Medical Center1
AstraZeneca1
Eli Lilly and Company1
Ewha Womans University Mokdong Hospital1
GeneOne Life Science, Inc.1
Hallym University Kangnam Sacred Heart Hospital1
International Vaccine Institute1
Korea University Guro Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronavirus Infections13
COVID-198
Virus Diseases4
Infections3
Lung Diseases3
Respiratory Tract Infections3
Pneumonia2
Pneumonia, Viral2
RNA Virus Infections2
Coronaviridae Infections1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.